Ottawa, Feb. 02, 2026 (GLOBE NEWSWIRE) -- The global smart insulin pens market size is calculated at USD 1.02 billion in 2026 and is expected to reach around USD 2.42 billion by 2034, growing at a ...
Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...
The FDA has approved a label expansion for once-weekly tirzepatide for adults with overweight and obesity, allowing the medication to be used with a pen that is equipped with four doses of the drug, ...
An Elite Daily editor tries at-home microneedling with the Dr. Pen A11 tool, consulting Jamie Bykowski (@skinwithjayme) for help with the process.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results